References
1. Dunn GP, Rinne ML, Wykosky J et al (2012)
Emerging insights into the molecular and cellular basis of glioblastoma. Genes Dev
26:756–784
2. Stupp R, Mason WP, van den Bent MJ et al
(2005) Radiotherapy plus concomitant and
adjuvant temozolomide for glioblastoma. N
Engl J Med 352:987–996
3. Davis ME (2016) Glioblastoma: overview of
disease and treatment. Clin J Oncol Nurs 20:
S2–S8
4. Lefranc F, Brotchi J, Kiss R (2005) Possible
future issues in the treatment of glioblastomas:
special emphasis on cell migration and the resistance of migrating glioblastoma cells to apoptosis. J Clin Oncol 23:2411–2422
5. Bro ¨sicke N, Faissner A (2015) Role of tenascins
in the ECM of gliomas. Cell Adhes Migr
9:131–140
6. Mathupala SP, Guthikonda M, Sloan AE (2006)
RNAi based approaches to the treatment of
malignant glioma. Technol Cancer Res Treat
5:261–269
7. Zukiel R, Nowak S, Wyszko E et al (2006) Suppression of human brain tumor with interference
RNA specific for tenascin-C. Cancer Biol Ther
5:1002–1007
8. Wyszko E, Rolle K, Nowak S et al (2008) A
multivariate analysis of patients with brain
tumors treated with ATN-RNA. Acta Pol
Pharm 65:677–684
9. Grabowska M, Grzes ´kowiak BF, Szutkowski K
et al (2019) Nano-mediated delivery of doublestranded RNA for gene therapy of glioblastoma
multiforme. PLoS One 14:e0213852
Delivery of dsRNA to Glioblastoma Cells
81
1. Dunn GP, Rinne ML, Wykosky J et al (2012)
Emerging insights into the molecular and cellular basis of glioblastoma. Genes Dev
26:756–784
2. Stupp R, Mason WP, van den Bent MJ et al
(2005) Radiotherapy plus concomitant and
adjuvant temozolomide for glioblastoma. N
Engl J Med 352:987–996
3. Davis ME (2016) Glioblastoma: overview of
disease and treatment. Clin J Oncol Nurs 20:
S2–S8
4. Lefranc F, Brotchi J, Kiss R (2005) Possible
future issues in the treatment of glioblastomas:
special emphasis on cell migration and the resistance of migrating glioblastoma cells to apoptosis. J Clin Oncol 23:2411–2422
5. Bro ¨sicke N, Faissner A (2015) Role of tenascins
in the ECM of gliomas. Cell Adhes Migr
9:131–140
6. Mathupala SP, Guthikonda M, Sloan AE (2006)
RNAi based approaches to the treatment of
malignant glioma. Technol Cancer Res Treat
5:261–269
7. Zukiel R, Nowak S, Wyszko E et al (2006) Suppression of human brain tumor with interference
RNA specific for tenascin-C. Cancer Biol Ther
5:1002–1007
8. Wyszko E, Rolle K, Nowak S et al (2008) A
multivariate analysis of patients with brain
tumors treated with ATN-RNA. Acta Pol
Pharm 65:677–684
9. Grabowska M, Grzes ´kowiak BF, Szutkowski K
et al (2019) Nano-mediated delivery of doublestranded RNA for gene therapy of glioblastoma
multiforme. PLoS One 14:e0213852
Delivery of dsRNA to Glioblastoma Cells
81